Mulmit

InMed Pharmaceuticals Inc.InMed Pharmaceuticals Inc.

INM Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-06-304,942,633-8,162,133-8.36
2024-06-304,597,730-7,675,550-20.14
2023-06-304,135,561-7,947,622-7,947,622-3.25
2022-06-301,089,435-18,600,117-18,600,117-33.17

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-16Vivo Opportunity, LLC19
2026-07-16Vivo Opportunity, LLC2
2026-07-15ADAR1 Capital Management, LLC1,000
2026-07-15Vivo Opportunity, LLC13,761
2026-07-15Vivo Opportunity, LLC1,389
2026-07-14Vivo Opportunity, LLC4,882
2026-07-14Vivo Opportunity, LLC493
2026-07-02Vivo Opportunity, LLC1,460
2026-07-02Vivo Opportunity, LLC147
2026-07-01Vivo Opportunity, LLC3,946
2026-07-01Vivo Opportunity, LLC398
2026-06-30Vivo Opportunity, LLC545

8-K events

FiledItems
2026-07-22Regulation FD disclosure · Other events · Financial statements and exhibits
2026-07-10Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-06-10Other events · Financial statements and exhibits
2026-05-19Entry into a material agreement · Change in control · Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-05-19Entry into a material agreement · Material modification to rights of security holders · Other events · Financial statements and exhibits
2026-05-07Regulation FD disclosure · Financial statements and exhibits
2026-04-27Entry into a material agreement · Material modification to rights of security holders · Other events · Financial statements and exhibits
2026-04-03Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.